Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Manufacturing, Other
- Agriculture
- Health and Safety
- Banking & Finance / Insurance / Legal
- Defense
- Aerospace & Air Transport
- Retail
- Waste and Recycling
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Food and Beverage
- Energy
- Construction & Construction Materials
Clinical Development Suppliers Serving Guyana
287 companies found
based inGamle Fredrikstad, NORWAY
EpiGuard is a Norwegian company established in 2015 by doctors and paramedics from the Oslo University Hospital, together with co-founders Inven2, Eker Group, and Hansen Protection. The company holds top level expertise with product development and ...
based inCambridge, MASSACHUSETTS (USA)
Sumitomo Pharma Oncology, Inc. is a developer of novel cancer therapeutics based in the U.S. and a wholly owned subsidiary of Sumitomo Pharma Co., Ltd. This U.S. entity, together with the oncology research and development teams in Japan, Cancer ...
based inFriedrichsdorf, GERMANY
PharmaLex is a leading provider of specialized services for the pharma, biotech and medtech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes ...
The Global Statistics and Data Science (GSDS) team at PharmaLex delivers analytical support for the development of medical products–from early research through pre-clinical to late phase studies, plus ...
based inBerlin, GERMANY
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We ...
based inYongin-si, SOUTH KOREA
Txinno Bioscience is developing anti-cancer treatments focused on two intertwined aspects of physiology of tumor tissue. Tcino Bioscience Co., Ltd. has secured and built core platform technologies such as small molecule innovative anticancer drug ...
based inNewport News, VIRGINIA (USA)
ivWatch was established with the mission to eliminate the harm done by IV infiltrations and extravasations to help improve patient outcomes. At ivWatch, we believe that by working together, we can enhance patient safety, advance patient care, and ...
based inYongin-si, SOUTH KOREA
Vivozon is a global innovative drug development company established in 2008. We built an efficacy-based new drug discovery system that is clearly distinct from the existing new drug development paradigm, and discovered the non- narcotic analgesic ...
Analgesic efficacy and safety of VVZ-149 injections for post-operative pain following laparoscopic colorectal surgery: a randomized, double-blind, parallel group, placebo-controlled, dose finding ...
based inLondon, UNITED KINGDOM
Founded in 2015, the original idea behind Airfinity was to systematically capture and structure the new science disseminated at conferences, a highly fragmented dataset. However, through working with medical associations and pharma companies, ...
Monitor, evaluate and anticipate the use of real world data and evidence around the globe, as well as its impact on the regulatory landscape. Real-world data (RWD) and real-world evidence (RWE) is playing an increasingly important role in how ...
based inCambridge, UNITED KINGDOM
Our business is organised to deliver our strategic priorities sustainably, supporting continued scientific innovation and commercial success. We focus on the discovery, development and commercialisation of prescription medicines in Oncology and ...
IVX-A12 is a bivalent combination of IVX-121 and IVX-241, a human metapneumovirus (hMPV) VLP vaccine candidate. IVX-A12 is being designed to target both RSV and hMPV in a single vaccine candidate. hMPV is being increasingly recognized as a major ...
based inMilford, MASSACHUSETTS (USA)
SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. Since the early 1980s, we have supported ...
based inOxford, UNITED KINGDOM
Physiomics are a leading oncology consultancy using proprietary state of the art Virtual TumourTM technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help ...
Pharmacokinetic (PK) & Pharmacodynamic (PD) modelling is often an integral component in the drug development process. PK involves studying the movement of a certain drug dose in the body. PD involves studying how a certain drug dose affects the ...
based inParis, FRANCE
Ariana Pharma is a leading Al driven Precision Medicine Company focused on accelerating clinical drug development and designing advanced therapeutic decision support systems. Using its KEM Explainable Artificial Intelligence (XAl) technology, Ariana ...
Using our pioneering eXplainable AI platform KEM® we design and execute Precision Medicine clinical trials, with an unparalleled successful track record across multiple therapeutic areas. Thanks to our XAI KEM® platform we integrate ...
based inLausanne, SWITZERLAND
Amazentis is an innovative life science company dedicated to employing breakthrough research and clinical science to bring advanced therapeutic nutrition products to life. We employ rigorous science to pioneer the discovery and clinical development ...
based inBoston, MASSACHUSETTS (USA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has multiple approved medicines that treat the underlying cause of cystic fibrosis (CF) — ...
Vertex is focused on developing transformative medicines for people with serious and life-threatening diseases. To do this, we conduct clinical trials to assess the safety and effectiveness of investigational ...
based inDaresbury, UNITED KINGDOM
Point of Care (PoC) medical diagnostics is a $ multi-billion global market. Driven by patient need for self monitoring and healthcare cost savings, hand-held devices or readers offering rapid diagnostic test results are fast replacing often slow and ...
Bio-AMD’s planned Generic PoC Magnetic Immunoassay Detection System (‘MIDS’), is expected to have a significantly enhanced sensitivity based on magnetic nano-particle manipulation and detection, capable of interpreting results on a ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
The biologics market is experiencing high growth. However, the path to clinic for biologics is complex, requiring a substantial amount of time and resources to ensure success. Sponsor companies are looking for an “all of the ...
based inCambridge, MASSACHUSETTS (USA)
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. ...
based inGuangming District, CHINA
Shenzhen Delica Medical Equipment Co., Ltd. was established in 1998, Delica is a national high-tech enterprise that is engaged in high-tech medical equipment research and development manufacturing. We are always focusing on neurology medical ...
based inGranada, SPAIN
Regemat 3D makes available to research and science a technology tailormade designed what born to integrate the advantages of the additive manufacturing with tissue engineering and applied to the regenerative medicine. The personalized configuration ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
